Pharmacological activity of (−)‐discretamine, a novel vascular α‐adrenoceptor and 5‐hydroxytryptamine receptor antagonist, isolated from Fissistigma glaucescens
Authors:
Open Access
- 1 October 1993
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 110 (2) , 882-888
Abstract
The pharmacological activity of (−)‐discretamine, isolated from Fissistigma glaucescens, was determined in rat isolated thoracic aorta, cardiac tissues and ventricular myocytes and guinea‐pig isolated trachea. (−)‐Discretamine was found to be an α1‐adrenoceptor blocking agent in rat thoracic aorta as revealed by its competitive antagonism of noradrenaline (pA2 = 7.20 ± 0.10)‐ or phenylephrine (pA2 = 7.60 ± 0.09)‐induced vasoconstriction. It was as potent as phentolamine (pA2 = 7.51 ± 0.10), but was more potent than yohimbine (pA2 = 6.18 ± 0.06). Removal of endothelium significantly increased the antagonistic potency of (−)‐discretamine on noradrenaline (pA2 = 7.52 ± 0.09)‐ or phenylephrine (pA2 = 7.90 ± 0.09)‐induced vasoconstriction. (−)‐Discretamine was also an α2‐adrenoceptor blocking agent (pA2 = 6.30 ± 0.15) and a 5‐hydroxytryptamine antagonist (pA2 = 6.87 ± 0.06), both in rat aorta denuded of endothelium. (−)‐Discretamine protected α‐adrenoceptors from alkylation by the irreversible blocking agent, phenoxybenzamine. [3H]‐inositol monophosphate formation caused by noradrenaline (3 μm) in rat thoracic aorta was suppressed by (−)‐discretamine (10 and 30 μm) and prazosin (3 μm). A high concentration of (−)‐discretamine (30 μm) did not affect the contraction induced by the thromboxane receptor agonist U‐46619, prostaglandin F2α (PGF2α), angiotensin II, high K+ or endothelin in rat aorta denuded of endothelium. Neither cyclic AMP nor cyclic GMP content of rat thoracic aorta was changed by (−)‐discretamine. Contraction of guinea‐pig trachea caused by histamine, leukotriene C4 or carbachol was not affected by (−)‐discretamine (30 μm). (−)‐Discretamine also did not block β1 or β2‐adrenoceptor‐mediated responses induced by isoprenaline in rat right atria and guinea‐pig trachea. A voltage clamp study in rat ventricular single myocytes revealed that sodium inward current, slow inward Ca2+ current or transient (Ito) and steady state (I800) outward current was not affected by (−)‐discretamine (30 μm). It is concluded that (−)‐discretamine is a selective α‐adrenoceptor and 5‐HT receptor antagonist in vascular smooth muscle.Keywords
This publication has 22 references indexed in Scilit:
- Cyclic nucleotides depress action potentials in cultured aortic smooth muscle cellsEuropean Journal of Pharmacology, 1987
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Modulation of Vascular Smooth Muscle Contraction by the EndotheliumAnnual Review of Physiology, 1986
- Cyclic guanosine monophosphate as a mediator of vasodilation.Journal of Clinical Investigation, 1986
- Physiologic Functions of Normal Endothelial CellsAnnals of the New York Academy of Sciences, 1985
- Alkaloids of formosan Fissistigma and Goniothalamus speciesPhytochemistry, 1985
- Prazosin Update A Review of its Pharmacological Properties and Therapeutic Use in Hypertension and Congestive Heart FailureDrugs, 1983
- Sodium current depression by lidocaine and quinidine in isolated ventricular cellsNature, 1981
- The pharmacology of prazosin, a novel antihypertensive agentLife Sciences, 1980
- How should values of pA2 and affinity constants for pharmacological competitive antagonists be estimated?Journal of Pharmacy and Pharmacology, 1978